APA (7th ed.) Citation

Bajraktari-Sylejmani, G., Linde, T. v., Burhenne, J., Haefeli, W. E., Sauter, M., & Weiß, J. (2022). Evaluation of PepT1 (SLC15A1) substrate characteristics of therapeutic cyclic peptides. Pharmaceutics, 14(8), . https://doi.org/10.3390/pharmaceutics14081610

Chicago Style (17th ed.) Citation

Bajraktari-Sylejmani, Gzona, Teresa von Linde, Jürgen Burhenne, Walter E. Haefeli, Max Sauter, and Johanna Weiß. "Evaluation of PepT1 (SLC15A1) Substrate Characteristics of Therapeutic Cyclic Peptides." Pharmaceutics 14, no. 8 (2022). https://doi.org/10.3390/pharmaceutics14081610.

MLA (9th ed.) Citation

Bajraktari-Sylejmani, Gzona, et al. "Evaluation of PepT1 (SLC15A1) Substrate Characteristics of Therapeutic Cyclic Peptides." Pharmaceutics, vol. 14, no. 8, 2022, https://doi.org/10.3390/pharmaceutics14081610.